Women's Health

Prevalence of gastroschisis, a birth defect where a baby's intestines stick outside the body, is increasing in the United States.

Contraceptive use was interrupted and more Medicaid-covered births occurred after Texas excluded Planned Parenthood from its fee-for-service family planning program.

This Continuing Education activity is supported by an educational grant from Teva Pharmaceuticals and Merck Sharp & Dohme Corp.

Community pharmacists can have a positive impact in terms of encouraging patients to be proactive about their health.

Overweight and obese women face a greater risk for complications during pregnancy.

Less is more for women receiving osteoporosis drug therapy, as new research suggests that this patient population may be overtreated.

Community pharmacists are ideal candidates to provide women with reliable information about their health.

There is conflicting information regarding the use of nitrofurantoin in pregnant patients.

Exposure to antidepressants during pregnancy does not impact a baby's risk for autism or attention-deficit/hyperactivity disorder after birth.

How many of these off-label uses have you seen before?

Pharmacists in Oregon rang in the New Year with permission to prescribe birth control.

Pharmacists should use caution when providing antibiotics to pregnant women, as prenatal antibiotic use has been linked to subsequent asthma in offspring.

Invasive fungal disease due to the genus Candida can be life threatening.

Women with type 2 diabetes have greater difficulty with exercise than those without the condition.

More than 100 women have filed a lawsuit after a birth control packaging error led to unplanned pregnancies.

Even though women are more likely to have a college education and white-collar job, they still typically earn less than their male peers.

Abbott's commitment to support working mothers with progressive benefits and extraordinary career opportunities was recognized today by Working Mother magazine.

Planned Parenthood funding cuts would save taxpayers $235 million over a decade, but also reduce health care access for nearly 400,000 women and children.

Allergan and the US Women's Health Alliance (USWHA) have announced an agreement to make Liletta available to patients across 26 Alliance health care groups nationwide.

The FDA has approved flibanserin (Addyi), the first drug to treat generalized hypoactive sexual desire disorder in premenopausal women.

Women with nodular thyroid disease or Hashimoto's thyroiditis face a higher risk of developing benign breast diseases.

Two different classes of drugs, aromatase inhibitors and bisphosphonates, may be able to reduce breast cancer mortality among postmenopausal women.

Using a common local anesthetic during surgery can reduce the likelihood of women developing chronic pain following the a mastectomy.

Making birth control available OTC would improve women's access to oral contraceptives while producing dramatic cost savings, a new National Center for Policy Analysis (NCPA) brief argues.

Don't miss these highlights from a recent issue of Pharmacy Times.